Researchers say 5 microRNAs characterize clinically unstable carotid atherosclerotic plaque and represent a potential pharmacologic target for plaque stabilization. br / iMedscape Medical News/i
In separate studies, researchers show that cognitive decline is steepest in the 2 years before death and that stimulating activities have a positive influence on cognitive health. Medscape Medical News
With ROCKET-AF meeting its primary end point and now being published in the New England Journal of Medicine, the next step for the new oral anticoagulant will be the FDA advisory panel review in September. br / iHeartwire/i
Bulbar symptoms such as dysphagia and dysarthria are frequent features of amyotrophic lateral sclerosis and can result in reductions in life expectancy and quality of life. Nature Clinical Practice Neurology
Synapse Biomedical announced FDA approval for the NeuRx system, which has already been approved in spinal cord injury, for use in assisting breathing in patients with ALS. Medscape Medical News